---
figid: PMC9450989__oncotarget-13-28104-g001
pmcid: PMC9450989
image_filename: oncotarget-13-28104-g001.jpg
figure_link: /pmc/articles/PMC9450989/figure/F1/
number: Figure 1
figure_title: ''
caption: (A) AZ, SFN, and the combination of AZ+SFN dose-dependently affect the ability
  for wound closure of typical H727 BC cells measured over 72 hours compared to untreated
  control cells using a scratch wound assay. (A) Pictures representative of two separate
  experiments (n = 2) performed in triplicates showing similar results.
article_title: 'Correction: Next-generation multimodality of nutrigenomic cancer therapy:
  sulforaphane in combination with acetazolamide actively target bronchial carcinoid
  cancer in disabling the PI3K/Akt/mTOR survival pathway and inducing apoptosis.'
citation: Reza Bayat Mokhtari, et al. Oncotarget. 2022;13:968-969.
year: '2022'

doi: 10.18632/oncotarget.28104
journal_title: Oncotarget
journal_nlm_ta: Oncotarget
publisher_name: Impact Journals LLC

keywords:
---
